LORETELLI, CRISTIAN
 Distribuzione geografica
Continente #
NA - Nord America 2.108
EU - Europa 882
AS - Asia 779
SA - Sud America 199
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 50
OC - Oceania 1
Totale 4.071
Nazione #
US - Stati Uniti d'America 2.043
SG - Singapore 293
IT - Italia 165
BR - Brasile 161
CN - Cina 137
VN - Vietnam 124
UA - Ucraina 122
RU - Federazione Russa 114
SE - Svezia 83
DE - Germania 78
IE - Irlanda 64
TR - Turchia 60
FI - Finlandia 51
FR - Francia 49
DK - Danimarca 47
GB - Regno Unito 47
HK - Hong Kong 41
IN - India 29
CA - Canada 27
KR - Corea 26
BD - Bangladesh 23
NL - Olanda 21
CI - Costa d'Avorio 19
MA - Marocco 16
MX - Messico 15
BE - Belgio 13
AR - Argentina 8
EC - Ecuador 7
IQ - Iraq 7
JP - Giappone 7
ZA - Sudafrica 7
ES - Italia 6
ID - Indonesia 6
MY - Malesia 6
VE - Venezuela 6
CL - Cile 5
CO - Colombia 5
PL - Polonia 5
RS - Serbia 5
GT - Guatemala 4
HN - Honduras 4
PK - Pakistan 4
TN - Tunisia 4
DO - Repubblica Dominicana 3
JM - Giamaica 3
PH - Filippine 3
SA - Arabia Saudita 3
SC - Seychelles 3
UY - Uruguay 3
CR - Costa Rica 2
CW - ???statistics.table.value.countryCode.CW??? 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
EU - Europa 2
LT - Lituania 2
NI - Nicaragua 2
NP - Nepal 2
PY - Paraguay 2
SV - El Salvador 2
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
GP - Guadalupe 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MT - Malta 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 4.025
Città #
Ashburn 340
Singapore 196
Chandler 193
Jacksonville 128
Fairfield 108
San Jose 100
Boardman 63
Dublin 63
Wilmington 63
Ann Arbor 62
Dallas 59
New York 59
Council Bluffs 56
Woodbridge 55
Houston 45
Beijing 43
Ho Chi Minh City 42
Centro 41
Hong Kong 40
Seattle 38
Cambridge 36
Los Angeles 34
Princeton 30
Hanoi 27
Lawrence 26
San Mateo 26
The Dalles 26
Lauterbourg 23
Moscow 23
Des Moines 22
Abidjan 19
Munich 18
Orem 18
Turin 18
Chennai 15
Turku 15
Atlanta 13
Chicago 13
São Paulo 13
Milan 12
Hefei 11
Helsinki 11
San Diego 11
Amsterdam 9
Brussels 9
Montreal 9
Buffalo 8
Mexico City 8
Santa Clara 8
Ancona 7
London 7
Brasília 6
Cagliari 6
Denver 6
Johannesburg 6
Tokyo 6
Brooklyn 5
Frankfurt am Main 5
Salt Lake City 5
San Francisco 5
Stockholm 5
Washington 5
Belgrade 4
Como 4
Curitiba 4
Da Nang 4
Haiphong 4
Izmir 4
Kilburn 4
Miano 4
New Delhi 4
Palermo 4
Paris 4
Phoenix 4
Poplar 4
Quito 4
Rio de Janeiro 4
Waanrode 4
Warsaw 4
Wuxi 4
Belo Horizonte 3
Boston 3
Bến Tre 3
City of London 3
Erbil 3
Fortaleza 3
Guangzhou 3
Guatemala City 3
Irving 3
Norwalk 3
Santiago 3
Wuhan 3
Addis Ababa 2
Ankara 2
Aparecida de Goiânia 2
Arzano 2
Baghdad 2
Bogotá 2
Calgary 2
Campinas 2
Totale 2.503
Nome #
An intronic mutation in MLH1 associated with familial colon and breast cancer. 211
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 205
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 199
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 176
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 175
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 171
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 170
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 166
A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy. 164
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 163
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 158
'Secrets and lies'--the difficulties of communicating within families with inherited cancer syndromes. 157
Sub-cellular localization analysis of MSH6 missense mutations does not reveal an overt MSH6 nuclear transport impairment. 150
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 148
Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features. 145
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 145
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 143
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 141
MSH2 splice site mutation and endometrial cancer. 138
MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system 138
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 138
Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression. 135
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 135
Effectiveness of the CRCAPRO program in identifying patients suspected for HNPCC. 134
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 134
Alterazione epigenetica di BRCA1 nei carcinomi mammari 132
Totale 4.071
Categoria #
all - tutte 17.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.844


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022147 0 0 0 3 4 11 11 12 13 34 16 43
2022/2023499 30 70 28 42 53 67 0 29 120 4 43 13
2023/2024234 34 4 25 25 39 52 6 8 0 3 5 33
2024/2025476 62 47 12 6 37 8 56 13 96 28 56 55
2025/20261.440 112 112 62 199 229 110 203 113 91 103 45 61
2026/2027265 62 37 56 110 0 0 0 0 0 0 0 0
Totale 4.071